The Valley Desk

NCT03373760 · Interventional trial

Durvalumab and Tremelimumab in Treating Patients With Recurrent Stage IV Lung Cancer

Overall registry status Completed

Phase 2

Conditions Recurrent Squamous Cell Lung Carcinoma, Stage IV Squamous Cell Lung Carcinoma AJCC v7

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov